[Application of DNA Microarray in Genetic Mutation Detection in Patients with Thalassemia].
Liu-Qun Qin, Tizhen Yan, Shiqiang Luo, Pengfei Cai, Lizhu Chen, Qingyan Zhong, Jing-Ren Wang, Qiu-Hua Wang, Dejian Yuan, Jun Huang
Abstract
Liu-Qun Qin, Tizhen Yan, Shiqiang Luo, Pengfei Cai, Lizhu Chen, Qingyan Zhong, Jing-Ren Wang, Qiu-Hua Wang, Dejian Yuan, Jun Huang
Abstract
OBJECTIVE: To perform dried blood spots thalassemia gene detection in patients with positive blood phenotypes by microarray technology, and evaluate its value in clinical detection. METHODS: DNA samples were extracted from dried blood spots of 410 patients. Microarray technology was used to detect 3 deletion and 3 non-deletion types of α-thalassemia and 19 β-thalassemia point mutations which were common gene mutions in China. RESULTS: (3 cases, 10.34%). CONCLUSION: for α-thalassemia and CD41-42 for β-thalassemia in Liuzhou, Guangxi Zhuang Autonomous Region. A and β-thalassemia can be detected at the same time by microarray chip technology in a high throughput manner.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To perform dried blood spots thalassemia gene detection in patients with positive blood phenotypes by microarray technology, and evaluate its value in clinical detection. METHODS: DNA samples were extracted from dried blood spots of 410 patients. Microarray technology was used to detect 3 deletion and 3 non-deletion types of α-thalassemia and 19 β-thalassemia point mutations which were common gene mutions in China. RESULTS: (3 cases, 10.34%). CONCLUSION: for α-thalassemia and CD41-42 for β-thalassemia in Liuzhou, Guangxi Zhuang Autonomous Region. A and β-thalassemia can be detected at the same time by microarray chip technology in a high throughput manner.
Key concepts: Thalassemia, Heterozygote advantage, Compound heterozygosity, Genotype, Point mutation, Genetics, Mutation, Microarray